Loading company…
TileBio develops AI models to interpret histopathology images for diagnostics and research.
Founded in 2025 and based in Glasgow, UK, TileBio develops AI foundation models that interpret histopathology images without human labeling. Its technology is intended for clinical diagnostics, biomarker discovery, and research. In March 2026, the company raised GBP 1.6 million in Seed funding led by Twin Path Ventures, with support from Scottish Enterprise and the University of Glasgow.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in